As of 2025-04-24, the Relative Valuation of Cassava Sciences Inc (SAVA) is (7.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.59 USD, the upside of Cassava Sciences Inc based on Relative Valuation is -542.1%.
The range of the Relative Valuation is (6.30) - (8.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 16.5x | 14.5x |
| Forward P/E multiples | 10.7x - 16.7x | 13.4x |
| Fair Price | (6.30) - (8.31) | (7.03) |
| Upside | -496.1% - -622.9% | -542.1% |
| Date | P/E |
| 2025-04-23 | -3.29 |
| 2025-04-22 | -3.16 |
| 2025-04-21 | -2.90 |
| 2025-04-17 | -2.86 |
| 2025-04-16 | -2.78 |
| 2025-04-15 | -2.84 |
| 2025-04-14 | -2.66 |
| 2025-04-11 | -2.52 |
| 2025-04-10 | -2.36 |
| 2025-04-09 | -2.44 |
| 2025-04-08 | -2.36 |
| 2025-04-07 | -2.60 |
| 2025-04-04 | -2.58 |
| 2025-04-03 | -2.52 |
| 2025-04-02 | -2.76 |
| 2025-04-01 | -2.74 |
| 2025-03-31 | -2.98 |
| 2025-03-28 | -3.27 |
| 2025-03-27 | -3.37 |
| 2025-03-26 | -3.47 |
| 2025-03-25 | -3.77 |
| 2025-03-24 | -5.56 |
| 2025-03-21 | -5.64 |
| 2025-03-20 | -5.48 |
| 2025-03-19 | -5.40 |
| 2025-03-18 | -5.54 |
| 2025-03-17 | -5.52 |
| 2025-03-14 | -5.54 |
| 2025-03-13 | -5.18 |
| 2025-03-12 | -5.42 |
| 2025-03-11 | -5.12 |
| 2025-03-10 | -5.30 |
| 2025-03-07 | -5.58 |
| 2025-03-06 | -5.60 |
| 2025-03-05 | -5.48 |
| 2025-03-04 | -5.32 |
| 2025-03-03 | -4.92 |
| 2025-02-28 | -4.76 |
| 2025-02-27 | -5.16 |
| 2025-02-26 | -4.56 |
| 2025-02-25 | -4.80 |
| 2025-02-24 | -4.96 |
| 2025-02-21 | -5.06 |
| 2025-02-20 | -5.36 |
| 2025-02-19 | -5.52 |
| 2025-02-18 | -5.10 |
| 2025-02-14 | -4.80 |
| 2025-02-13 | -4.72 |
| 2025-02-12 | -4.62 |
| 2025-02-11 | -4.58 |